Clinical Trial Update: Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT) [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating the combination of plinabulin and pegfilgrastim in people with multiple myeloma undergoing autologous stem cell transplant, and th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Pegfilgrastim (pegfilgrastim)
• Plinabulin (plinabulin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING